Answers are grounded in this paper and cite their sources.
Dermatomyositis (DM) is a rare autoimmune condition involving skin manifestations often resistant to standard treatments such as immunosuppressants and antimalarials. Biopsies show elevated inflammatory cells such as CD4+ T cells, dendritic cells, and cytokines. Lenabasum, a selective cannabinoid receptor 2 agonist, has demonstrated significant benefits in treating autoimmune skin diseases.
No takes yet. Share an insight, caveat, or question.
Stone et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: